The Monitoring Study
The Monitoring Study: Evaluating the Effect of Remote Monitoring For Hypoglycemia on Bionic Pancreas Safety and Efficacy
Sponsor: Massachusetts General Hospital
A NA clinical study on Type1diabetes, this trial is completed. The trial is conducted by Massachusetts General Hospital and has accumulated 11 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
-
Aug 2018 — Feb 2020 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 6 earlier versions
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Jun 2017 — Mar 2018 [monthly]
Active Not Recruiting NA
Status: Not Yet Recruiting → Active Not Recruiting
-
Apr 2017 — Jun 2017 [monthly]
Not Yet Recruiting NA
Phase: PHASE2_PHASE3 → NA
-
Feb 2017 — Apr 2017 [monthly]
Not Yet Recruiting PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Massachusetts General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .